Medtronic plc Medtronic plc

Medtronic plc

MDT

Classifica tra le azioni #183
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Prezzo delle azioni
$94.70
Ultima sincronizzazione: 2026-10-16
Capitalizzazione di mercato
$121.14B
Variazione (1 giorno)
-1.36%
Variazione (1 anno)
-1.13%
Paese
IE
Scambia Medtronic plc (MDT)

Categoria

Healthcare
Margine operativo per Medtronic plc (MDT)
Margine operativo al May 2026 TTM: 17.86%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Medtronic plc, il margine operativo attuale (TTM) è 17.86%. Alla fine del 2024, il margine operativo era 15.89%.
Storico del margine operativo per Medtronic plc da 2000 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) 17.86% 0.56%
2025 17.76% 11.77%
2024 15.89% -9.51%
2023 17.56% -3.25%
2022 18.15% 21.89%
2021 14.89% -10.14%
2020 16.57% -19.21%
2019 20.51% -7.49%
2018 22.17% 22.35%
2017 18.12% -2.53%
2016 18.59% 0.00%
2015 18.59% -17.08%
2014 22.42% -15.49%
2013 26.53% -4.22%
2012 27.70% -1.04%
2011 27.99% -7.50%
2010 30.26% 27.52%
2009 23.73% -12.14%
2008 27.01% -11.15%
2007 30.40% -7.35%
2006 32.81% -4.20%
2005 34.25% -2.17%
2004 35.01% 1.13%
2003 34.62% 3.28%
2002 33.52% -0.92%
2001 33.83% 0.77%
2000 33.57% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
17.03% -99.05%
US
22.03% -98.77%
US
21.46% -98.80%
US
0.00% -
DE
28.09% -98.43%
US
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.